(Q51515564)

6 April 2018

title

Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction. (English)

1 reference

6 April 2018

1 reference

1 reference

1 reference

4

1 reference

6 April 2018

author name string

Platten HP

1

1 reference

6 April 2018

Schweizer E

2

1 reference

6 April 2018

Dilger K

3

1 reference

6 April 2018

Klotz U

5

1 reference

6 April 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

6 April 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

6 April 2018

volume

63

1 reference

6 April 2018

issue

5

1 reference

6 April 2018

page(s)

552-560

1 reference

6 April 2018

Geriatric Pharmacology: Basic and Clinical Considerations*

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Intravenous midazolam for upper gastrointestinal endoscopy: a study of 800 consecutive cases relating dose to age and sex of patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Small bolus injections of intravenous midazolam for upper gastrointestinal endoscopy: a study of 788 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Effects of age, gender and oral contraceptives on intramuscular midazolam pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

No evidence of a genetic polymorphism in the oxidative metabolism of midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Relationship between plasma concentration and effect of midazolam after oral and intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

A comparison of the concentration-effect relationships of midazolam for EEG-derived parameters and saccadic peak velocity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Pulse oximetry during minor oral surgery with and without intravenous sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Gerontokinetics--a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Prescribing CNS drugs for elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Pharmacokinetic changes in the elderly. Do they contribute to drug abuse and dependence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Pharmacokinetic Optimisation of Drug Therapy in Elderly Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Comparison of midazolam and diazepam in doses of comparable potency during gastroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Comparison of the recovery characteristics of diazepam and midazolam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Pharmacokinetics of midazolam in the aged.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Physiologic and temporal variation in hepatic elimination of midazolam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

The erythromycin breath test predicts the clearance of midazolam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Pharmacokinetic-pharmacodynamic relationships for benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Relation of sedation and amnesia to plasma concentrations of midazolam in surgical patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Pharmacokinetic-pharmacodynamic modeling of midazolam effects on the human central nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Electroencephalographic effects of benzodiazepines. II. Pharmacodynamic modeling of the electroencephalographic effects of midazolam and diazepam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Quantification of the EEG effect of midazolam by aperiodic analysis in volunteers. Pharmacokinetic/pharmacodynamic modelling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Pharmacokinetic-pharmacodynamic modelling of the interaction between flumazenil and midazolam in volunteers by aperiodic EEG analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Simultaneous modeling of the pharmacokinetics and pharmacodynamics of midazolam and diazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

The German counterpart to McGill Pain Questionnaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Pulse oximetry--clinical implications and recent technical developments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Dihydrocodeine: a new opioid substrate for the polymorphic CYP2D6 in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Simultaneous determination of dihydrocodeine and dihydromorphine in serum by gas chromatography-tandem mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Intra-operative patient-controlled sedation. Comparison of patient-controlled propofol with anaesthetist-administered midazolam and fentanyl.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

A comparison of 1- and 3-minute lockout periods during patient-controlled sedation with midazolam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Response to intravenous midazolam sedation in general dental practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

Pharmacokinetic studies in elderly people. Are they necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990106-0

10.1016/S0009-9236(98)90106-0

7 January 2021

Identifiers

DOI

1 reference

6 April 2018

1 reference

6 April 2018